STOCK TITAN
  1. Home
  2. Sec-filings
  3. XGN
  4. [EFFECT] Exagen Inc. SEC Filing

[EFFECT] Exagen Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 2, 2025 4:01 P.M.
Form: S-3
CIK: 0001274737
Company Name: EXAGEN INC.
File Number: 333-288199

Source: View Original Filing on SEC EDGAR

Stock XGN logo
Exagen Inc.

NASDAQ:XGN

XGN Rankings

#4143 Ranked by Market Cap
N/A Ranked by Dividends

XGN Latest News

Aug 6, 2025
Exagen Inc. to Participate in Third Quarter Investor Conferences
Jul 29, 2025
Exagen Inc. Reports Strong Q2 2025 Results
Jul 17, 2025
Exagen Inc. Appoints Chas McKhann to Board of Directors
Jul 15, 2025
Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025
Jun 23, 2025
Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics

XGN Latest SEC Filings

Aug 14, 2025
[SCHEDULE 13G/A] Exagen Inc. SEC Filing
Aug 14, 2025
[SCHEDULE 13G/A] Exagen Inc. SEC Filing
Jul 29, 2025
[10-Q] Exagen Inc. Quarterly Earnings Report
Jul 29, 2025
[8-K] Exagen Inc. Reports Material Event
Jul 17, 2025
[8-K] Exagen Inc. Reports Material Event

XGN Stock Data

210.13M
15.12M
19.64%
57.81%
6.4%
Diagnostics & Research
Services-medical Laboratories
Link
United States
VISTA